and MDS conditioning regimen for allogeneic stem cell transplantation in AML pharmacokinetic results of a myeloablative, reduced-toxicity Once-daily intravenous busulfan and fludarabine: clinical and
Year: 2013
Type: article
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2741597282
